SALVAT Completes Enrollment of Phase III Study for a New Combination in Acute Otitis Media in Pediatric Patients With Tympanostomy Tubes (AOMT)

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BARCELONA, Spain--(BUSINESS WIRE)--SALVAT announced that clinical trial enrollment has completed for the Phase III study evaluating the efficacy and safety of a new otic solution containing Ciprofloxacin and Fluocinolone in patients with Acute Otitis Media.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC